Research suggests that tomatoes and their key compound lycopene may support prostate health through several biological mechanisms, including reduced oxidative DNA damage, lower PSA levels, and increased programmed cell death in cancerous prostate tissue. Studies indicate that regular tomato consumption is associated with measurable increases in lycopene levels in both blood and prostate tissue, and broader dietary reviews consistently place lycopene-rich red foods among the phytochemicals most relevant to prostate health outcomes. The available evidence includes a small pre-surgical intervention trial, a feasibility randomized controlled trial in African-American men with elevated PSA, and two narrative reviews examining fruit and vegetable consumption across cancer risk broadly. That said, the clinical studies are small and preliminary in nature, and most findings should be interpreted cautiously until larger, more rigorous trials confirm these associations — the evidence is directionally consistent but not yet conclusive.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Role of lycopene and tomato products in prostate health. | Review | 2005 | Supports | 100 |
| Vegetables, fruits and phytoestrogens in the prevention of diseases. | Review | 2004 | Supports | 95 |
| Applying science to changing dietary patterns. | Review | 2001 | Supports | 90 |
| Diet adherence dynamics and physiological responses to a tomato product whole... | RCT | 2013 | Supports | 85 |